Liability

  • Read more: Tips from a former medical student – Part II

    Tips from a former medical student – Part II

    By Deborah Cho [See Part I here] Last week, I wrote the first of a two-part series on tips that may be helpful for law students and lawyers interested in or working in health/medical law.  I continue with Tip #4 here. 4. If you need to learn about a disease, procedure, or drug that you…

  • Read more: Tips from a former medical student – Part I

    Tips from a former medical student – Part I

    By Deborah Cho As a student in the Disability Litigation Clinic, one of the many fantastic clinics here at Harvard Law school, I’ve come to appreciate the value of hands-on experience as an essential component of legal education.  One issue that we as students are often faced with, however, is a lack of familiarity with…

  • Read more: Professional Licensing Boards and Antitrust Liability

    Professional Licensing Boards and Antitrust Liability

    [Blogger’s Note: I am very pleased to share this post by my colleague at Seton Hall Law, Tara Adams Ragone, in which she discusses North Carolina Board of Dental Examiners v. FTC, drawing on both her scholarly work on the intersection of health care and antitrust law and on her deep experience prosecuting medical licensing actions…

  • Read more: Update on Litigation in Looney v. Moore (SUPPORT Trial Class Action)

    Update on Litigation in Looney v. Moore (SUPPORT Trial Class Action)

    By Michelle Meyer For those closely following the litigation over this clinical trial, a few updates. On January 22, the district court ruled on defendants’ motions to dismiss plaintiffs’ third amended complaint. That complaint named as defendants the director of the IRB, the chair of the IRB, the other members of the IRB (“the IRB…

  • Read more: Standards of Care and Patient Advocacy in Religiously Affiliated Hospitals

    Standards of Care and Patient Advocacy in Religiously Affiliated Hospitals

    By Nadia N. Sawicki The New York Times reported today that the ACLU has filed a lawsuit against the United States Conference of Catholic Bishops on behalf of Tamesha Means, a patient at Mercy Health Partners in Michigan.  The suit alleges that Means suffered physical and emotional harm as a result of the Conference of Bishops’ ethical…

  • Read more: Recommended Reading: “A First Amendment Approach to Generic Drug Manufacturer Tort Liability”

    Recommended Reading: “A First Amendment Approach to Generic Drug Manufacturer Tort Liability”

    By Jeremy Kreisberg The November 2013 issue of the Yale Law Journal features a very interesting comment on an important issue at the intersection of health law and policy. A First Amendment Approach to Generic Drug Manufacturing, by Connor Sullivan, argues that the First Amendment principles underlying the Supreme Court’s opinion in Sorrell v. IMS…

  • Read more: The Co-Pay Coupon Controversy: Time for Detente?

    The Co-Pay Coupon Controversy: Time for Detente?

    By Kate Greenwood Cross-Posted at Health Reform Watch At the end of last month, the Secretary of Health and Human Services Kathleen Sebelius made headlines when, in a letter addressed to Representative Jim McDermott (D-WA), she announced that “[qualified health plans], other programs related to the Federally-facilitated Marketplace, and other programs under Title I of…

  • Read more: A Case to Watch: Heimeshoff v. Hartford Life & Accident Ins. Co.

    A Case to Watch: Heimeshoff v. Hartford Life & Accident Ins. Co.

    By Jeremy Kreisberg A little over two weeks ago, the Supreme Court heard oral argument in a rather obscure ERISA case—Heimsehoff v. Hartford Life & Accident Ins. Co.  The case asks a rather basic question without a readily apparent answer: when a beneficiary of an ERISA-regulated insurance plan seeks to claim benefits, may the statute…

  • Read more: Kaiser v. Pfizer and the Question of Who Pays When Fraudulent Pharmaceutical Promotion Has Its Intended Effect

    Kaiser v. Pfizer and the Question of Who Pays When Fraudulent Pharmaceutical Promotion Has Its Intended Effect

    By Kate Greenwood Cross-Posted at Health Reform Watch On April 3, 2013, the First Circuit issued decisions in three cases in which third-party payers sought compensation from Pfizer for damages sustained as a result of fraudulent pharmaceutical promotion.  The decisions were noteworthy because in them the First Circuit lent its imprimatur to a causal chain…

  • Read more: More on the Debate over Vaccines and Liability

    More on the Debate over Vaccines and Liability

    By Arthur Caplan Bill of Health Contributor Art Caplan has a new opinion piece online at MedScape: “YOUR Fault if Your Unvaccinated Child Makes Someone Sick.” (Note: Registration to access MedScape is free.) Are you doing enough to make sure that your patients and their kids are getting vaccinated? Sometimes we leave this for the…